Inotropic effects of diadenosine monophosphate (AP1A) in isolated human cardiac preparations

Journal of Cardiovascular Pharmacology

Volumn 35, Issue 6, 2000, Pages 881-886

  Zimmermann, N ^a   Nacke, P R ^a   Neumann, J ^a,b   Winter, J ^a   Gams, E ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Diadenosine polyphosphates; Human heart; Inotropy

Indexed keywords

DIADENOSINE MONOPHOSPHATE; DIADENOSINE POLYPHOSPHATE; INOTROPIC AGENT; ISOPRENALINE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; DRUG MECHANISM; DRUG STRUCTURE; HEART MUSCLE CONTRACTILE FORCE; HUMAN; HUMAN TISSUE; INOTROPISM; ISOLATED HEART; PRIORITY JOURNAL;

ADENOSINE DEAMINASE; ATRIAL FUNCTION; CALCIUM; DINUCLEOSIDE PHOSPHATES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; HEART; HEART ATRIA; HUMANS; ISOPROTERENOL; MYOCARDIAL CONTRACTION; XANTHINES;

EID: 0034036259     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200006000-00008     Document Type: Article

References (8)

1. Baxi MD, Vishwanatha JK. Diadenosine polyphosphates: their biological and pharmacological significance. J Pharmacol Toxicol Methods 1995;33:121-8.
2. Miras-Portugal MT, Gualix J, Pintor J. The neurotransmitter role of diadenosine polyphosphates. FEBS Lett 1998;430:78-82.
3. Pintor J, Gualix J, Miras-Portugal MT. Dinucleotide receptor modulation by protein kinases (protein kinases A and C) and protein phosphatases in rat brain synaptic terminals. J Neurochem 1997;68:2552-7.
4. Ripoll C, Martin F, Manuel-Rovira J, Pintor J, Miras-Portugal MT, Soria B. Diadenosine polyphosphates: a novel class of glucose-induced intracellular messengers in the pancreatic beta-cell. Diabetes 1996;45:1431-4.
5. Schlüter H, Gross I, Bachmann J, et al. Adenosine (5′) oligophospho-(5′) guanosines and guanosine (5′) oligophospho-(5′) guanosines in human platelets. J Clin Invest 1998;101:682-8.
6. Verspohl EJ, Johannwille B. Diadenosine polyphosphates in insulin-secreting cells: interaction with specific receptors and degradation. Diabetes 1998;47:1727-34.
7. 4-tetraphosphate and other alarmones. J Biol Chem 1992;267: 4652-7.
8. 4-tetraphosphate: a novel antiplatelet agent. Proc Natl Acad Sci U S A 1997;94:4034-9.